All Patients (n=96) | All Patients (n=96) | AF Undetected (n=68) | AF Undetected (n=68) | AF Undetected (n=68) | AF Detected (n=28) | AF Detected (n=28) | P-Value | ||
Mean Age | 66.8 | ±12.9 | 65.2 | ±12.7 | ±12.7 | 70.7 | ±12.8 | 0.055 | |
Sex | Sex | 0.339 | |||||||
Female | 58.0 | (60.4%) | 39.0 | (57.4%) | (57.4%) | 19.0 | (67.9%) | ||
Male | 38.0 | (39.6% | 29.0 | (42.6%) | (42.6%) | 9.0 | (32.1%) | ||
BMI | 28.5 | ±6.3 | 28.5 | ±6.7 | ±6.7 | 28.6 | ±5.5 | 0.942 | |
Stroke Location | Stroke Location | .121 | |||||||
ACA | 10.0 | (11.0%) | 10.0 | (15.2%) | (15.2%) | 0.0 | (0.0%) | ||
MCA | 43.0 | (47.3%) | 32.0 | (48.5%) | (48.5%) | 11.0 | (44.0%) | ||
PCA | 6.0 | (6.6%) | 5.0 | (7.6%) | (7.6%) | 1.0 | (4.0%) | ||
Basal Ganglia | 10.0 | (11.0%) | 7.0 | (10.6%) | (10.6%) | 3.0 | (12.0%) | ||
Cerebellar | 6.0 | (6.6%) | 4.0 | (6.1%) | (6.1%) | 2.0 | (8.0%) | ||
Brainstem | 4.0 | (4.4%) | 2.0 | (3.0%) | (3.0%) | 2.0 | (8.0%) | ||
Multiple | 10.0 | (11.0%) | 6.0 | (9.1%) | (9.1%) | 4.0 | (16.0%) | ||
TIA | 2.0 | (2.2%) | 0.0 | (0.0%) | (0.0%) | 2.0 | (8.0%) | ||
CVA Laterality | CVA Laterality | .941 | |||||||
Right | 44.0 | (47.8%) | 31.0 | (47.0%) | (47.0%) | 13.0 | (50.0%) | ||
Left | 38.0 | (41.3%) | 28.0 | (42.4%) | (42.4%) | 10.0 | (38.5%) | ||
Bilateral | 10.0 | (10.9%) | 7.0 | (10.6%) | (10.6%) | 3.0 | (11.5%) | ||
Medical History | Medical History | ||||||||
Prior Stroke | 40.0 | (41.7%) | 26.0 | (38.2%) | (38.2%) | 14.0 | (50.0%) | 0.288 | |
HTN | 86.0 | (89.6%) | 62.0 | (91.2%) | (91.2%) | 24.0 | (85.7%) | 0.426 | |
DM | 52.0 | (54.2%) | 39.0 | (57.4%) | (57.4%) | 13.0 | (46.4%) | 0.329 | |
HLD | 58.0 | (61.1%) | 41.0 | (60.3%) | (60.3%) | 17.0 | (63.0%) | 0.810 | |
CAD | 18.0 | (18.9%) | 10.0 | (14.7%) | (14.7%) | 8.0 | (29.6%) | 0.094 | |
PAD | 4.0 | (4.2%) | 0.0 | (0.0%) | (0.0%) | 4.0 | (14.3%) | *** | |
CHF | 3.0 | (3.1%) | 2.0 | (2.9%) | (2.9%) | 1.0 | (3.6%) | *** | |
Smoking | Smoking | 0.291 | |||||||
Current | 23.0 | (23.9%) | 17.0 | (25%) | (25%) | 6.0 | (21.4%) | ||
Past | 14.0 | (14.6%) | 8.0 | (11.8%) | (11.8%) | 6.0 | (21.4%) | ||
Non-smoker | 59.0 | (61.5%) | 43.0 | (63.2%) | (63.2%) | 16.0 | (57.1%) | ||
Risk Scores | Risk Scores | ||||||||
CHA2DS2VASc | 4.4 | ±1.7 | 4.4 | ±1.7 | ±1.7 | 4.4 | ±1.8 | 0.889 | |
ASCVD | 23.9 | ±17.0 | 22.2 | ±16.4 | ±16.4 | 27.7 | ±17.8 | 0.169 | |
Labs | Labs | ||||||||
LDL | 112.0 | ±43.6 | 107.7 | ±42.3 | ±42.3 | 122.4 | ±45.8 | 0.140 | |
Cholesterol | 178.6 | ±48.8 | 173.2 | ±46.7 | ±46.7 | 191.7 | ±52.1 | 0.096 | |
HDL | 45.5 | ±12.6 | 45.1 | ±13.1 | ±13.1 | 46.4 | ±11.6 | 0.656 | |
HbA1C | 7.1 | ±2.1 | 7.1 | ±2.1 | ±2.1 | 7.0 | ±2.2 | 0.759 | |
Troponin | 0.04 | ±014 | 0.05 | ±0.018 | ±0.018 | 0.02 | ±0.01 | 0.476 | |
BNP | 109.6 | ±292.2 | 144.3 | ±420.5 | ±420.5 | 69.6 | ±52.5 | 0.463 | |
eGFR | 53.9 | ±12.4 | 53.2 | ±13.4 | ±13.4 | 55.5 | ±10.0 | 0.427 | |
Medications | Medications | ||||||||
Aspirin | 70.0 | (72.9%) | 48.0 | (70.6%) | (70.6%) | 22.0 | (78.6%) | 0.424 | |
Statin | 71.0 | (74.7%) | 53.0 | (79.1%) | (79.1%) | 18.0 | (64.3%) | 0.130 | |
Beta Blockers | 32.0 | (33.7%) | 23.0 | (34.3%) | (34.3%) | 9.0 | (32.1%) | 0.837 | |
ACE/ARB/ARNI | 41.0 | (43.2%) | 30.0 | (44.8%) | (44.8%) | 11.0 | (39.3%) | 0.622 | |
Non-DHP CCB | 29.0 | (30.5%) | 25.0 | (37.3%) | (37.3%) | 4.0 | (14.3%) | 0.026 | |
Cardiac Findings | Cardiac Findings | ||||||||
Ejection Fraction (TTE) | 59.3 | ±9.0 | 58.0 | ±4.9 | ±4.9 | 59.9 | ±10.2 | 0.370 | |
LA Size (mm) | 34.0 | ±6.3 | 34.6 | ±5.4 | ±5.4 | 33.8 | ±6.7 | 0.612 | |
P wave duration (ms) | 104.9 | ±14.8 | 104.0 | ±18.7 | ±18.7 | 105.4 | ±13.0 | 0.681 | |
P wave area (mV*ms) | 1.8 | ±0.7 | 1.7 | ±0.7 | ±0.7 | 1.9 | ±0.7 | 0.166 | |
P wave terminal force (µV*ms) | 4161.0 | ±2558.8 | 4506.4 | ±2209.1 | ±2209.1 | 4008.1 | ±2702.2 | 0.403 | |
*** p-values are not reported given small sample. P-values: continuous variables are compared using independent sample t-tests and categorical values are compared using Pearson Chi-Square tests where appropriate. | *** p-values are not reported given small sample. P-values: continuous variables are compared using independent sample t-tests and categorical values are compared using Pearson Chi-Square tests where appropriate. | *** p-values are not reported given small sample. P-values: continuous variables are compared using independent sample t-tests and categorical values are compared using Pearson Chi-Square tests where appropriate. | *** p-values are not reported given small sample. P-values: continuous variables are compared using independent sample t-tests and categorical values are compared using Pearson Chi-Square tests where appropriate. | *** p-values are not reported given small sample. P-values: continuous variables are compared using independent sample t-tests and categorical values are compared using Pearson Chi-Square tests where appropriate. | *** p-values are not reported given small sample. P-values: continuous variables are compared using independent sample t-tests and categorical values are compared using Pearson Chi-Square tests where appropriate. | *** p-values are not reported given small sample. P-values: continuous variables are compared using independent sample t-tests and categorical values are compared using Pearson Chi-Square tests where appropriate. | *** p-values are not reported given small sample. P-values: continuous variables are compared using independent sample t-tests and categorical values are compared using Pearson Chi-Square tests where appropriate. | *** p-values are not reported given small sample. P-values: continuous variables are compared using independent sample t-tests and categorical values are compared using Pearson Chi-Square tests where appropriate. | *** p-values are not reported given small sample. P-values: continuous variables are compared using independent sample t-tests and categorical values are compared using Pearson Chi-Square tests where appropriate. |